
The Lancet Commission called for global cooperation to end the continued spread of COVID-19 and effectively prevent future pandemics.
Nina Cosdon is the associate editor for Contagion. Before joining MJH Life Sciences, she graduated magna cum laude from Denison University in 2021 with a degree in Communication. You can find her reading, hiking, or antiquing, or by emailing her at ncosdon@mjhlifesciences.com.

The Lancet Commission called for global cooperation to end the continued spread of COVID-19 and effectively prevent future pandemics.

Why do some children develop polio-like paralysis after contracting enterovirus? Here’s everything we know about the rare but increasing reports of acute flaccid myelitis.

COVID-19 viral load rebound occurred in 2.3% of nirmatrelvir–ritonavir (Paxlovid) recipients and in 1.7% of placebo recipients.

Adenovirus was determined to have caused most cases of hepatitis of unknown origin in children.

Investigators noted 2 distinct phases of HIV virus levels, meaning any infected cells that survive treatment can become latent, only to reignite HIV infection after antiretroviral therapy is stopped.


Texas judge Reed O’Connor ruled that requiring employers to cover the medical expense of HIV PrEP is a violation of religious freedom.

Valneva’s COVID-19 vaccine candidate, VLA2001, demonstrated superior virus-neutralizing antibodies compared to the AstraZeneca vaccine.

Injection drug users who received accessible care treatment at a syringe service program were almost 3 times as likely to complete their hepatitis C treatment than people who received usual care.

AIVITA’s COVID-19 vaccine candidate contains only the subject’s primed immune cells.

A study published this week by the American Heart Association found myocarditis was more common after COVID-19 infection than after COVID-19 vaccination.

2 Washington, DC monkeypox patients presented with lesions and proctitis, and were treated with oral tecovirimat.

Pfizer-BioNTech and Moderna have developed new booster shots optimized for Omicron. They could be approved as soon as Labor Day.

The incubation period of the original, wild-type COVID-19 strain was 6.65 days, while the Omicron variant's incubation period has shortened to 3.42 days.

Read this week’s top infectious disease stories you may have missed, including Dr. Anthony Fauci’s announcement.

The European Commission approved lenacapavir to treat multidrug-resistant HIV infection. The long-acting HIV treatment regimen will be marketed as Sunlenca and available in injection or tablet form.

56% of adults with evidence of Omicron seropositivity did not know they were infected.

Risk of severe maternal morbidity was highest during the period when Delta was the predominant COVID-19 variant.

Home Run Inn Frozen Foods sausage pizzas have been recalled after consumers reported finding metal in the pizza.

6 months after acute COVID-19 infection, patients had elevated usage of health care services to treat post-COVID conditions.

Neutralization of BA.4 and BA.5 dropped significantly for individuals who were infected with a previous strain of Omicron, even if they were also vaccinated.

Ongoing wastewater surveillance in San Diego seeks to track and predict monkeypox infection surges.

Asymptomatic individuals in low-risk settings do not have to quarantine after COVID-19 exposure, CDC says.

Langya virus, a new type of henipavirus, was identified in at least 35 people in eastern China. The virus is suspected to have infected shrews before jumping to humans.

Expanding Medicaid and reducing stigma can bolster equitable HIV PrEP access, Dr. Patrick Sullivan says.

An FDA advisory committee will meet on September 22, 2022 to decide whether to approve a biologics license application (BLA) for Ferring’s recurrent C difficile biotherapeutic, RBX2660.

At AIDS 2022, Gilead presented data suggesting Biktarvy was a safe and effective complete HIV treatment regimen, including for those coinfected with hepatitis B.

After 5 years of treatment, fostemsavir improved immunologic response and virologic outcome in patients with highly resistant HIV infection.

What steps need taken to end viral hepatitis by 2030? “It all comes down to testing,” said Carl Schmid, executive director of the HIV+Hepatitis Policy Institute.

Viral hepatitis “can and should be managed within primary care,” says Dr. Thomas Robertson.